Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kosuke Takemura
Institutions:
The Cancer Institute Hospital,
Japanese Foundation For Cancer Research
Observed institutions:
The Cancer Institute Hospital,
Japanese Foundation For Cancer Research
ORCID:
0000-0003-4321-6074
Observed ORCID:
0000-0003-4321-6074
OpenAlex ID:
A5124744768
Bladder-sparing strategies for non-muscle-invasive bladder cancer after bacillus Calmette–Guérin failure: a systematic review
2026
·
Takahiko Soma
, Kosuke Takemura
, et al.
·
BMJ Oncology
·
2
PDF
Clinical and Molecular Validation of the Very Favorable IMDC Risk Group in Metastatic Renal Cell Carcinoma
2026
·
Martin Zarba
, Eddy Saad
, et al.
·
JAMA Network Open
·
1
Real-world (RW) characteristics, management, and outcomes of genomically defined mismatch repair deficient (MMR-d) and aggressive variant prostate cancer (AVPC).
2026
·
Steven Yip
, Amanda Williams Gibson
, et al.
·
Journal of Clinical Oncology
International metastatic renal cell carcinoma database consortium classification and regression tree analysis to characterize objective response rates to first line in metastatic renal cell carcinoma
2026
·
Martin Zarba
, Dylan O’Sullivan
, et al.
·
Frontiers in Oncology
PDF
Ip56-23 Hypoalbuminemia as an Independent Prognostic Factor in Clinically Node-positive Upper Tract Urothelial Carcinoma Without Distant Metastasis
2026
·
Ayano Ishida
, Noboru Numao
, et al.
·
The Journal of Urology
PDF
Ip36-19 Lymphovascular Invasion and Nodal Positivity as Useful Markers for Selecting Candidates for Adjuvant Nivolumab in High-risk Muscle-invasive Urothelial Carcinoma
2026
·
Hiroki Shimoda
, Noboru Numao
, et al.
·
The Journal of Urology
PDF
Show more works
View as search
Works count:
6
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type